Suppr超能文献

预处理前淋巴细胞计数降低与异基因造血干细胞移植后 BK 病毒相关性出血性膀胱炎相关。

Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

机构信息

Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Int Immunopharmacol. 2023 Aug;121:110515. doi: 10.1016/j.intimp.2023.110515. Epub 2023 Jun 26.

Abstract

BACKGROUND

BK virus-associated hemorrhagic cystitis (BKV-HC) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). It can cause morbidity and may increase treatment-related mortality. Previous studies showed that the occurrence of BKV-HC was related to various factors. However, there are still many controversial factors. It is not clear whether BKV-HC will affect the long-term prognosis of patients.

OBJECTIVE

We aimed to identify risk factors for BKV-HC after allo-HSCT and evaluate the effect of BKV-HC on overall survival (OS) and progression- free survival (PFS) of patients.

STUDY DESIGN

We retrospectively analyzed the clinical data of 93 patients who underwent allo-HSCT. Univariate and multivariate analysis were used to identify risk factors for BKV-HC. The Kaplan-Meier method was used to estimate OS and PFS. A difference was considered statistically significant if P < 0.05.

RESULTS

A total of 24 patients developed BKV-HC. The median occurrence time of BKV-HC was 30 (range:8-89) days after transplantation, and the median duration was 25.5 (range:6-50) days. Multivariate logistic regression analysis indicated that peripheral blood lymphocyte count <1 × 10/L before conditioning (OR = 4.705, P = 0.007) and haploidentical transplantation (OR = 13.161, P = 0.018) were independent risk factors for BKV-HC. The 3-year OS rate was 85.9% (95%CI:62.1%-95.2%) in the BKV-HC group and 73.1% (95%CI: 58.2%-88.0%) in the non-BKV-HC group. There was no significant difference between the two groups (P = 0.516). The 3-year PFS rate was 76.3% (95%CI: 57.9%-94.7%) in the BKV-HC group and 58.1% (95%CI: 39.5%-76.7%) in the non-BKV-HC group. There was no significant difference in the two groups (P = 0.459). The severity of BKV-HC was not related to the OS and PFS of the patients (P value was 0.816 and 0.501, respectively).

CONCLUSION

Haploidentical transplantation and decreased peripheral blood lymphocyte count before conditioning increased the risk of BKV-HC after allo-HSCT. The occurrence of BKV-HC after allo-HSCT and the severity of which did not affect OS and PFS of the patients.

摘要

背景

BK 病毒相关性出血性膀胱炎(BKV-HC)是异基因造血干细胞移植(allo-HSCT)后的一种严重并发症。它可导致发病率增加,并可能增加治疗相关死亡率。先前的研究表明,BKV-HC 的发生与多种因素有关。然而,仍有许多有争议的因素。BKV-HC 是否会影响患者的长期预后尚不清楚。

目的

本研究旨在确定 allo-HSCT 后 BKV-HC 的危险因素,并评估 BKV-HC 对患者总生存(OS)和无进展生存(PFS)的影响。

研究设计

我们回顾性分析了 93 例接受 allo-HSCT 的患者的临床数据。采用单因素和多因素分析确定 BKV-HC 的危险因素。采用 Kaplan-Meier 法估计 OS 和 PFS。如果 P<0.05,则认为差异具有统计学意义。

结果

共有 24 例患者发生 BKV-HC。BKV-HC 的中位发生时间为移植后 30 天(范围:8-89 天),中位持续时间为 25.5 天(范围:6-50 天)。多因素 logistic 回归分析表明,预处理时外周血淋巴细胞计数<1×10/L(OR=4.705,P=0.007)和单倍体相合移植(OR=13.161,P=0.018)是 BKV-HC 的独立危险因素。BKV-HC 组的 3 年 OS 率为 85.9%(95%CI:62.1%-95.2%),非 BKV-HC 组为 73.1%(95%CI:58.2%-88.0%)。两组间无显著差异(P=0.516)。BKV-HC 组的 3 年 PFS 率为 76.3%(95%CI:57.9%-94.7%),非 BKV-HC 组为 58.1%(95%CI:39.5%-76.7%)。两组间无显著差异(P=0.459)。BKV-HC 的严重程度与患者的 OS 和 PFS 无关(P 值分别为 0.816 和 0.501)。

结论

预处理时单倍体相合移植和外周血淋巴细胞计数减少增加了 allo-HSCT 后 BKV-HC 的风险。allo-HSCT 后发生 BKV-HC 及其严重程度并不影响患者的 OS 和 PFS。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验